Max J. Gordon

Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib

Max J. Gordon, Michael C. Churnetski, Hamood Alqahtani et al. · Cancer · 2018 · 87 citations

Medicine, Immunology, Oncology +15

Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis

Adam S. Kittai, Ying Huang, Max J. Gordon et al. · Transplantation and Cellular Therapy · 2020 · 60 citations

Medicine, Hematology, Oncology +17

Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy

Irl Brian Greenwell, Ashley D. Staton, Michael J. Lee et al. · Cancer · 2018 · 56 citations · Full text

Medicine, Hematology, Oncology +13

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model

Max J. Gordon, Andy Kaempf, Andrea Sitlinger et al. · Clinical Cancer Research · 2021 · 53 citations · Full text

Public Health, Biostatistics, Oncology +17

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Geoffrey Shouse, Andy Kaempf, Max J. Gordon et al. · Blood Advances · 2023 · 49 citations · Full text

Medicine, Hematology, Oncology +16